(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 1.3% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Quidelortho's revenue in 2025 is $2,764,700,000.On average, 4 Wall Street analysts forecast QDEL's revenue for 2025 to be $183,806,781,967, with the lowest QDEL revenue forecast at $182,623,667,336, and the highest QDEL revenue forecast at $185,313,824,524. On average, 4 Wall Street analysts forecast QDEL's revenue for 2026 to be $191,448,640,754, with the lowest QDEL revenue forecast at $189,338,916,426, and the highest QDEL revenue forecast at $192,973,130,787.
In 2027, QDEL is forecast to generate $200,501,919,117 in revenue, with the lowest revenue forecast at $199,716,106,484 and the highest revenue forecast at $201,287,731,749.